Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Assets Average: 2013-2025

Historic Assets Average for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $170.7 million.

  • Fortress Biotech's Assets Average rose 25.12% to $170.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.7 million, marking a year-over-year increase of 25.12%. This contributed to the annual value of $155.9 million for FY2024, which is 32.50% down from last year.
  • Latest data reveals that Fortress Biotech reported Assets Average of $170.7 million as of Q3 2025, which was up 0.99% from $169.0 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Assets Average high stood at $413.0 million for Q3 2021, and its period low was $135.7 million during Q4 2024.
  • Moreover, its 3-year median value for Assets Average was $165.6 million (2023), whereas its average is $174.5 million.
  • Per our database at Business Quant, Fortress Biotech's Assets Average spiked by 62.71% in 2021 and then plummeted by 51.82% in 2023.
  • Quarterly analysis of 5 years shows Fortress Biotech's Assets Average stood at $402.2 million in 2021, then dropped by 23.18% to $308.9 million in 2022, then tumbled by 48.52% to $159.0 million in 2023, then fell by 14.70% to $135.7 million in 2024, then increased by 25.12% to $170.7 million in 2025.
  • Its Assets Average was $170.7 million in Q3 2025, compared to $169.0 million in Q2 2025 and $161.1 million in Q1 2025.